These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 2105269)

  • 21. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.
    Gauthier YP; Tournier JN; Paucod JC; Corre JP; Mock M; Goossens PL; Vidal DR
    Infect Immun; 2009 Mar; 77(3):1197-207. PubMed ID: 19114543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen.
    Peachman KK; Rao M; Alving CR; Burge R; Leppla SH; Rao VB; Matyas GR
    Infect Immun; 2006 Jan; 74(1):794-7. PubMed ID: 16369043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE
    FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produce protective antigen.
    Barnard JP; Friedlander AM
    Infect Immun; 1999 Feb; 67(2):562-7. PubMed ID: 9916059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax.
    Cohen S; Mendelson I; Altboum Z; Kobiler D; Elhanany E; Bino T; Leitner M; Inbar I; Rosenberg H; Gozes Y; Barak R; Fisher M; Kronman C; Velan B; Shafferman A
    Infect Immun; 2000 Aug; 68(8):4549-58. PubMed ID: 10899854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anthrax spores make an essential contribution to vaccine efficacy.
    Brossier F; Levy M; Mock M
    Infect Immun; 2002 Feb; 70(2):661-4. PubMed ID: 11796596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
    Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W
    Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological analysis of cell-associated antigens of Bacillus anthracis.
    Ezzell JW; Abshire TG
    Infect Immun; 1988 Feb; 56(2):349-56. PubMed ID: 3123387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacillus subtilis spore vaccines displaying protective antigen induce functional antibodies and protective potency.
    Oh Y; Kim JA; Kim CH; Choi SK; Pan JG
    BMC Vet Res; 2020 Jul; 16(1):259. PubMed ID: 32723323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy assessment of a triple anthrax chimeric antigen as a vaccine candidate in guinea pigs: challenge test with
    Abdous M; Hasannia S; Salmanian AH; Arab SS
    Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):495-502. PubMed ID: 34259590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against
    Majumder S; Das S; Somani VK; Makam SS; Kingston JJ; Bhatnagar R
    Front Immunol; 2019; 10():498. PubMed ID: 30941133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs.
    Little SF; Ivins BE; Fellows PF; Friedlander AM
    Infect Immun; 1997 Dec; 65(12):5171-5. PubMed ID: 9393812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.
    Cybulski RJ; Sanz P; McDaniel D; Darnell S; Bull RL; O'Brien AD
    Vaccine; 2008 Sep; 26(38):4927-39. PubMed ID: 18657585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A heat-inducible Bacillus subtilis bacteriophage phi 105 expression system for the production of the protective antigen of Bacillus anthracis.
    Baillie LW; Moore P; McBride BW
    FEMS Microbiol Lett; 1998 Jun; 163(1):43-7. PubMed ID: 9631544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs.
    Ivins B; Fellows P; Pitt L; Estep J; Farchaus J; Friedlander A; Gibbs P
    Vaccine; 1995 Dec; 13(18):1779-84. PubMed ID: 8701593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
    Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice.
    Wilson MK; Vergis JM; Alem F; Palmer JR; Keane-Myers AM; Brahmbhatt TN; Ventura CL; O'Brien AD
    Infect Immun; 2011 Aug; 79(8):3012-9. PubMed ID: 21576337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracis.
    Miller J; McBride BW; Manchee RJ; Moore P; Baillie LW
    Lett Appl Microbiol; 1998 Jan; 26(1):56-60. PubMed ID: 9489035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.
    Koehler SM; Buyuk F; Celebi O; Demiraslan H; Doganay M; Sahin M; Moehring J; Ndumnego OC; Otlu S; van Heerden H; Beyer W
    BMC Vet Res; 2017 Jul; 13(1):220. PubMed ID: 28701192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
    Stokes MG; Titball RW; Neeson BN; Galen JE; Walker NJ; Stagg AJ; Jenner DC; Thwaite JE; Nataro JP; Baillie LW; Atkins HS
    Infect Immun; 2007 Apr; 75(4):1827-34. PubMed ID: 17145938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.